External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer

Cédric Vallier,Pierre-Henri Savoie,Jean-Robert Delpero,F. Bladou,Gwenaelle Gravis,Naji Salem,Dominique Rossi,Jochen Walz

External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer

2014

Cédric Vallier
Pierre-Henri Savoie
Jean-Robert Delpero
F. Bladou
Gwenaelle Gravis
Naji Salem
Dominique Rossi
Jochen Walz

Objective To validate the Heidenreich criteria for patient selection for unilateral retroperitoneal lymph node dissection (RPLND) for residual masses after chemotherapy for nonseminomatous germ cell tumor (NSGCT).

Keywords:

Retroperitoneal lymph node dissection
Post-chemotherapy
Testicular cancer
Medicine
Surgery
Chemotherapy
Internal medicine
residual mass
Nephrology
external validation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations